Skip to main content

Table 2 HLA-A single amino acid polymorphisms**

From: Lack of HLA predominance and HLA shared epitopes in biliary Atresia

Positions

Amino acid

Patients (176) n (%)

Controls (329) n (%)

Odds Ratio

Pu value*

Pc value*

9

F

134(76.14)

251(76.29)

1.0

0.97

NS

9

S

47(26.70)

108(32.83)

0.8

0.16

NS

9

T

31(17.61)

55(16.72)

0.9

0.80

NS

9

Y

70(39.77)

123(37.39)

0.9

0.60

NS

44

K

44(25.00)

84(25.53)

1.0

0.90

NS

56

R

21(11.93)

39(11.85)

1.0

0.98

NS

62

E

33(18.75)

89(27.05)

0.7

0.04

NS

62

G

82(46.59)

160(48.63)

1.0

0.66

NS

62

Q

113(64.20)

197(59.88)

0.9

0.34

NS

62

R

57(32.39)

94(28.57)

0.9

0.37

NS

63

N

57(32.39)

94(28.57)

0.9

0.37

NS

65

G

32(18.18)

89(27.05)

0.7

0.03

NS

66

K

104(59.09)

223(67.78)

0.9

0.05

NS

66

N

152(86.36)

257(78.12)

0.9

0.02

NS

67

M

44(25.00)

84(25.53)

1.0

0.90

NS

70

H

157(89.20)

310(94.22)

0.9

0.04

NS

70

Q

92(52.27)

164(49.85)

1.0

0.60

NS

73

I

20(11.36)

37(11.25)

1.0

0.97

NS

74

D

163(92.61)

296(89.97)

1.0

0.33

NS

74

H

82(46.59)

160(48.63)

1.0

0.66

NS

76

A

66(37.50)

112(34.04)

0.9

0.44

NS

76

E

55(31.25)

119(36.17)

0.9

0.27

NS

76

V

151(85.80)

270(82.07)

1.0

0.28

NS

77

D

151(85.80)

270(82.07)

1.0

0.28

NS

77

N

102(57.95)

187(56.84)

1.0

0.81

NS

79

R

46(26.14)

111(33.74)

0.8

0.08

NS

80

I

46(26.14)

111(33.74)

0.8

0.08

NS

81

A

46(26.14)

111(33.74)

0.8

0.08

NS

82

L

46(26.14)

111(33.74)

0.8

0.08

NS

83

R

46(26.14)

111(33.74)

0.8

0.08

NS

90

D

85(48.30)

150(45.59)

0.9

0.56

NS

95

I

152(86.36)

259(78.72)

0.9

0.04

NS

95

L

37(21.02)

104(31.61)

0.7

0.01

NS

95

V

76(43.18)

145(44.07)

1.0

0.85

NS

97

I

109(61.93)

184(55.93)

0.9

0.19

NS

97

M

74(42.05)

175(53.19)

0.8

0.02

NS

97

R

99(56.25)

198(60.18)

0.9

0.39

NS

99

F

32(18.18)

89(27.05)

0.7

0.03

NS

105

P

92(52.27)

167(50.76)

1.0

0.75

NS

105

S

158(89.77)

297(90.27)

1.0

0.86

NS

107

G

164(93.18)

296(89.97)

1.0

0.23

NS

107

W

82(46.59)

161(48.94)

1.0

0.62

NS

114

H

108(61.36)

232(70.52)

0.9

0.04

NS

114

Q

48(27.27)

85(25.84)

0.9

0.73

NS

114

R

109(61.93)

193(58.66)

0.9

0.48

NS

116

D

142(80.68)

241(73.25)

0.9

0.06

NS

116

Y

108(61.36)

232(70.52)

0.9

0.04

NS

127

K

115(65.34)

250(75.99)

0.9

0.01

NS

127

N

143(81.25)

243(73.86)

0.9

0.06

NS

142

I

157(89.20)

284(86.32)

1.0

0.35

NS

142

T

94(53.41)

191(58.05)

0.9

0.32

NS

144

Q

77(43.75)

138(41.95)

1.0

0.70

NS

145

H

94(53.41)

191(58.05)

0.9

0.32

NS

145

R

157(89.20)

284(86.32)

1.0

0.35

NS

149

T

28(15.91)

41(12.46)

0.8

0.28

NS

150

V

44(25.00)

84(25.53)

1.0

0.90

NS

151

R

59(33.52)

112(34.04)

1.0

0.91

NS

152

A

57(32.39)

119(36.17)

0.9

0.40

NS

152

E

65(36.93)

96(29.18)

0.8

0.07

NS

152

V

140(79.55)

291(88.45)

0.9

0.01

NS

156

L

143(81.25)

257(78.12)

1.0

0.41

NS

156

Q

40(22.73)

101(30.70)

0.7

0.06

NS

156

R

44(25.00)

84(25.53)

1.0

0.90

NS

156

W

49(27.84)

93(28.27)

1.0

0.92

NS

158

V

44(25.00)

84(25.53)

1.0

0.90

NS

161

D

44(25.00)

56(17.02)

0.7

0.03

NS

163

R

79(44.89)

144(43.77)

1.0

0.81

NS

166

D

73(41.48)

155(47.11)

0.9

0.23

NS

166

E

163(92.61)

295(89.67)

1.0

0.28

NS

167

G

73(41.48)

155(47.11)

0.9

0.23

NS

167

W

163(92.61)

295(89.67)

1.0

0.28

NS

  1. *Pu, uncorrected P values; Pc, corrected P values.
  2. † Polymorphic amino acid positions 3, 9, 12, 14, 17, 19, 31, 35, 43, 44, 56, 62, 63, 65, 66, 67, 70, 73, 74, 76, 77, 79, 80, 81, 82, 83, 90, 95, 97, 99, 102, 105, 107, 109, 114, 116, 127, 142, 144, 149, 150, 151, 152, 156, 158, 161, 163, 166, 167, 171.
  3. ** Not displaying amino acid residues that were present in 90% or greater in both patient and control groups, or were present in 10% or fewer in both patient and control groups.